SciClone and Zensun Enter Into a Licensing Agreement for Novel Chronic Heart ... Marketwire (press release) Neucardin is a genetically engineered recombinant peptide fragment of neuregulin-1 that has been clinically shown to directly improve cardiac function, reverse ventricular remodeling and increase the survival of heart failure patients. Six Phase 2 ... SciClone (SCLN) Notes Possible Q1 Revenue Impact Due to NovaMed Accounting |